KRAS and neoplasm: Of the 4 patients with tumor tissue KRAS mutations but no cfDNA KRAS mutations, one of them had a low cell-free DNA yield (1.7 ng), while the other three had high yields (>8 ng) that were similar to the two patients with KRAS mutations detected in both plasma and tumor tissue.